Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6191731 | European Journal of Surgical Oncology (EJSO) | 2015 | 8 Pages |
Abstract
SLNB was successful in 98.7% of elderly patients with high sensitivity and a low false negative rate. Only 2% of our elderly patients appeared too frail for SLNB. Age alone should not be a contraindication to SLNB and CLND for melanoma.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
T.E. Grotz, C.A. Puig, S. Perkins, K. Ballman, T.J. Hieken,